CAR-T Congress

Starts:  Mar 20, 2018 12:00 AM (ET)
Ends:  Mar 22, 2018 12:00 AM (ET)

This program has already taken place.

The CAR-T Congress gathered thought leaders from biotech, big pharma, academia and investment and addressed the challenges and opportunities of CAR-T therapies in both liquid and solid tumors.  Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event provided an in depth view into this expansive area.

Exploring ground-breaking developments into CAR-T therapy, the event provided the opportunity to collaborate to create a commercially viable, effective and safe therapy.

To find out more information or to register, please click here.

#2018
#Biomarkers
#ClinicalTrials
#BoneCancers
#BrainCancers
#BreastCancers
#ColorectalCancer
#GastrointestinalCancers
#GenitourinaryCancers
#HeadandNeckCancers
#HematologicMalignancies
#LungCancers
#SkinCancers
#Article
#InPersonEvent
#Collaboration
#CollaborativeEvent
#Adverse Events
#Cellular Therapies
#ImmuneCheckpointInhibitors
#Toxicities
#Clinician
#Oncologist
#Researcher

Location

Hilton Boston Dedham Hotel
25 Allied Drive
Dedham, MA 02026